| Actinobacterial diversity in volcanic caves and associated geomicrobiological interactions C Riquelme, JJ Marshall Hathaway, MLN Enes Dapkevicius, AZ Miller, ... Frontiers in microbiology 6, 1342, 2015 | 120 | 2015 |
| The cave microbiome as a source for drug discovery: reality or pipe dream? S Ghosh, N Kuisiene, N Cheeptham Biochemical pharmacology 134, 18-34, 2017 | 107 | 2017 |
| Light-mediated activities of some Thai medicinal plant teas N Cheeptham, GHN Towers Fitoterapia 73 (7-8), 651-662, 2002 | 103 | 2002 |
| Fundamental research questions in subterranean biology S Mammola, IR Amorim, ME Bichuette, PAV Borges, N Cheeptham, ... Biological Reviews 95 (6), 1855-1872, 2020 | 97 | 2020 |
| Cure from the cave: volcanic cave actinomycetes and their potential in drug discovery T Sadoway, D Rule, K Watson, P Moote, LC Soliman, N Azad, K Donkor, ... International Journal of Speleology 42 (1), 5, 2013 | 73 | 2013 |
| Whole Genome Sequencing and Metabolomic Study of Cave Streptomyces Isolates ICC1 and ICC4 JT Gosse, S Ghosh, A Sproule, D Overy, N Cheeptham, CN Boddy Frontiers in microbiology 10, 1020, 2019 | 46 | 2019 |
| A conservation roadmap for the subterranean biome JJ Wynne, FG Howarth, S Mammola, RL Ferreira, P Cardoso, TD Lorenzo, ... Conservation Letters 14 (5), e12834, 2021 | 45 | 2021 |
| Isolation and identification of biosurfactant producing actinomycetes from soil. I Thampayak, N Cheeptham, W Pathom-Aree, P Leelapornpisid, ... | 43 | 2008 |
| Biotechnological potential of Actinobacteria from Canadian and Azorean volcanic caves C Riquelme, ML Enes Dapkevicius, AZ Miller, Z Charlop-Powers, S Brady, ... Applied Microbiology and Biotechnology 101, 843-857, 2017 | 40 | 2017 |
| Eosin-methylene blue agar plates protocol A Lal, N Cheeptham American Society for Microbiology, 2007 | 39 | 2007 |
| Advances and challenges in studying cave microbial diversity N Cheeptham Cave microbiomes: A novel resource for drug discovery, 1-34, 2012 | 35 | 2012 |
| Susceptibility of Clinical Moraxella catarrhalis Isolates in British Columbia to Six Empirically Prescribed Antibiotic Agents T Bandet, S Whitehead, E Blondel-Hill, K Wagner, N Cheeptham Canadian Journal of Infectious Diseases and Medical Microbiology 25 (3), 155-158, 2014 | 31 | 2014 |
| Cave microbiomes: A novel resource for drug discovery N Cheeptham Springer Science & Business Media, 2012 | 30 | 2012 |
| In situ cultured bacterial diversity from iron curtain cave, Chilliwack, British Columbia, Canada S Ghosh, E Paine, R Wall, G Kam, T Lauriente, PC Sa-Ngarmangkang, ... Diversity 9 (3), 36, 2017 | 27 | 2017 |
| Starch agar protocol A Lal, N Cheeptham American Society for Microbiology 1, 1-9, 2012 | 24 | 2012 |
| The effects of UV light on the antimicrobial activities of cave actinomycetes D Rule, N Cheeptham International Journal of Speleology 42 (2), 7, 2013 | 22 | 2013 |
| Eosin Methylene blue agar N Cheeptham Thomson Rivers University, Canada, 2012 | 22 | 2012 |
| New sources of antibiotics: caves N Cheeptham, C Sáiz-Jiménez Caister Academic Press, 2015 | 17 | 2015 |
| Determination of susceptibility to fosfomycin and tigecycline of Enterobacteriaceae, particularly Escherichia coli isolates, producing extended-spectrum β-lactamases from … C Beuk, C Hill, S Whitehead, E Blondel-Hill, K Wagner, N Cheeptham The Canadian Journal of Infectious Diseases & Medical Microbiology 24 (3), e80, 2013 | 17 | 2013 |
| Cave microbiomes: a novel resource for drug discovery CR Gabriel, DE Northup, N Cheeptham Cave Microbiomes 1, 85-108, 2013 | 16 | 2013 |
